Can an AI Combination of Ultrasound and Molecular Data Predict Chemotherapy Response in Breast Cancer Patients?

Researchers found that a deep convolutional neural network, incorporating B-mode ultrasound and shear wave elastography data, had nearly an 88 percent sensitivity rate for predicting neoadjuvant chemotherapy response in patients with breast cancer.

Read the full article here

Related Articles